Canada's main stock index bounced back on Friday, though it seemed headed for its biggest weekly drop in more than a year, as investors fretted about the direction of global interest rates in the ...
Entree Resources Ltd. (T.ETG) hit a new 52-week high of $2.41 Friday. No news stories available today. Hydreight Technologies ...
Jefferies said SoftBank Group Corp's (TYO:9984) over its $100 billion U.S. investment pledge may limit share buybacks and constrain stock upside. Brokerage downgraded the stock to “hold.” The ...
Canada's main stock index fell on Friday, on course for its biggest weekly drop in more than a year, as investors fretted about the path of global rates next year, a possible U.S. government shutdown ...
Nike has been downgraded to Market Perform from Outperform by Telsey Advisory Group (TAG) on Friday following its second-quarter fiscal 2025 earnings call, the first led by new CEO Elliott Hill. The ...
Carnival Corporation (LON:CCL) reported fourth-quarter earnings that exceeded analyst expectations, driving its U.S.-listed shares up 4.3% in early trading on Wednesday. The cruise operator posted ...
AAR CORP. (NYSE: AIR) shares were off slightly Friday, as the leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced today that it has entered into a ...
CACI International Inc (NYSE: CACI) announced today that it has been named to the inaugural Forbes 2025 list of America’s Most Trusted Companies. “This recognition reflects CACI’s enduring commitment ...
SEALSQ Corp (NASDAQ: LAES) shares shot higher early Friday. The Geneva, Switzerland-based company, one which focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware ...
Shares of Tesla (NASDAQ: TSLA) continued to slide on Friday, in what appeared to be a case of investors taking profits from ...
Oracle shares came under pressure premarket Friday, down around 1.3% after Monness, Crespi, Hardt downgraded the stock to Sell from Neutral and set a 12-month price target of $130, below its current ...
Shares of Danish pharmaceutical giant Novo Nordisk (NYSE:NOVO) plummeted Friday after reporting results in a late-stage trial for its experimental CagriSema weight loss drug that missed expectations.